Enhancing Effect of Silver Nitrate Nanoparticles as an Adjuvant in Formulation of Polyvalent Foot and Mouth Disease Vaccine
Keywords:
Abstract
Vaccination of susceptible animals against foot-and-mouth disease (FMD) is a wellestablished strategy to combat the disease. The protective immune response induced by vaccines can vary according to the kinds of adjuvants. The advance in nanotechnology has enabled us to utilize particles in the Nano size. So using novel immune adjuvants has an auxiliary role in the amplification of immune responses. Many investigators agree the size of the adjuvant particles is crucial to their adjuvant activities. The main aim of this study is to evaluate the effect of Silver nitrate nanoparticles (AgNPs) 5-10 nm particle size as an adjuvant in the polyvalent foot and mouth disease vaccine (containing FMD viruses O / PanAsia2, A/Iran 05, SAT2/VII/Lib-12 (SAT2/ Lib) and SAT2/VII/Ghb-12(SAT2/Ghb). A comprehensive immunological study was conducted in three calve groups vaccinated subcutaneously with three formulae of polyvalent FMD where group (A) was vaccine formula with AgNPs adjuvant, group (B) the vaccine formula adjuvanted with both MontanidISA 206 oil and AgNPs, while group (C) the vaccine formula with MontanidISA 206 oil adjuvant. A forth calve group kept without vaccination as control.
Downloads
- Article PDF
- TEI XML Kaleidoscope (download in zip)* (Beta by AI)
- Lens* NISO JATS XML (Beta by AI)
- HTML Kaleidoscope* (Beta by AI)
- DBK XML Kaleidoscope (download in zip)* (Beta by AI)
- LaTeX pdf Kaleidoscope* (Beta by AI)
- EPUB Kaleidoscope* (Beta by AI)
- MD Kaleidoscope* (Beta by AI)
- FO Kaleidoscope* (Beta by AI)
- BIB Kaleidoscope* (Beta by AI)
- LaTeX Kaleidoscope* (Beta by AI)
How to Cite
References
S Alexandersen, Z Zhang, A Donaldson, A Garland (2003) The Pathogenesis and Diagnosis of Foot-and-Mouth Disease. 129(1), 1-36.
J Arzt, N Juleff, Z Zhang, L Rodriguez (2011) The Pathogenesis of Foot-and-Mouth Disease I: Viral Pathways in Cattle. 58(4), 291-304.
H Bahnemann (1975) Binary ethylenimine as an inactivant for foot-and-mouth disease virus and its application for vaccine production. 47(1), 47-56.
Paul Barnett, Robert Statham, Wilna Vosloo, Daniel Haydon (2003) Foot-and-mouth disease vaccine potency testing: determination and statistical validation of a model using a serological approach. 21(23), 3240-3248.
J C Batista, Ronaldo, S C Mário, H Mazzoni, Chacham (2010) First-principles investigation of electrochemical properties of gold nanoparticles. 21(6).
Fred Brown (2003) The history of research in foot-and-mouth disease. 91(1), 3-7.
A Castellheim, O Brekke, T Espevik, M Harboe, T Mollnes (2009) Innate Immune Responses to Danger Signals in Systemic Inflammatory Response Syndrome and Sepsis. 69(6), 479-491.
Daniel Pierre, L Berengere, V Nuria, S Remi, L Alice, G Alix, K Bruno, C Jean, M, Ignacio (2019) Silver Nanoparticle-Adjuvanted Vaccine Protects Against Lethal 9 Year 2020 Influenza Infection Through Inducing BALT and IgAmediated Mucosal Immunity. 217, 119308.
H El-Watany, M Shawky, O Roshdy, S El-Kelany (1999) Relationship between cellular and humoral immunity responses in animal vaccinated with FMD vaccine. 1110(1458).
G Frial, A Lubna, F Ayad, Al (2018) Effect of silver nanoparticles that extracted by Staphylococcus aureuson cellular immunity in rabbits. 10(6), 1623-1624.
M Ferreira (1976) Au-delà de la crise. 21-22.
Sangiliyandi Gurunathan, Kyung-Jin Lee, Kalimuthu Kalishwaralal, Sardarpasha Sheikpranbabu, Ramanathan Vaidyanathan, Soo Eom (2009) Antiangiogenic properties of silver nanoparticles. 30(31), 6341-6350.
M Grubman (2005) Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals. 33, 227-234.
Marvin Grubman, Barry Baxt (2004) Foot-and-Mouth Disease. 17(2), 465-493.
C Hamblin, I Barnett, R Hedger (1986) A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus I. Development and method of ELISA. 93(1), 115-121.
M Hiam, M Fakhry And Eman, El-Garf (2010) Bivalent foot-and-mouth-disease and colibacillus vaccine - contains foot-and-mouth-disease vaccinating antigens and Escherichia coli K99 attachment antigens. 1(1), 51-51.
A Ismail, S El-Mahdy, W Mossad, Abd El-Krim, A Abou El-Yazid, M, Ali (2013) Optimization of the Inactivation Process of FMD Virus Serotype SAT-2 by Binary Ethyleneimine (BEI). 201(3), 117-124.
Seung-Heon Shin, Mi-Kyung Ye, Hae-Sic Kim, Hyung-Suk Kang (2007) The effects of nano-silver on the proliferation and cytokine expression by peripheral blood mononuclear cells. 7(13), 1813-1818.
Stephen Kaba, Clara Brando, Qin Guo, Christian Mittelholzer, Senthilkumar Raman, David Tropel, Ueli Aebi, Peter Burkhard, David Lanar (2009) A Nonadjuvanted Polypeptide Nanoparticle Vaccine Confers Long-Lasting Protection against Rodent Malaria. 183(11), 7268-7277.
R Killington, A Stokes, J Hierholzer (1996) Virus purification. 71-89.
B Mahy, H Kangro Unknown Title.
R Knudsen, C Groocock, A Andersen (1979) Immunity to foot-and-mouth disease virus in guinea pigs: clinical and immune responses. 24(3), 787-792.
M Lázaro, K André, P Ana (2017) Role of Metallic Nanoparticles in Vaccinology: Implications for Infectious Disease Vaccine Development. 08.
Ian Macpherson, Michael Stoker (1962) Polyoma transformation of hamster cell clones-an investigation of genetic factors affecting cell competence. 16(2), 147-151.
Padma Malyala, Manmohan Singh (2010) Micro/Nanoparticle Adjuvants: Preparation and Formulation with Antigens. 626, 91-101.
A Mansour (2001) Some studies on the effect of mycotoxins on immune response of FMD vaccinated animals.
G Mercedes, D Timothy, C Trevor, R Martin, E Michael (1996) Recognition of foot-and-mouth disease virus and its capsid protein VP1 by bovine peripheral T lymphocytes. 77, 727-735.
Oie (2012) Quarterly report April - June 1988 / International Rescue Committee.
Juan Pacheco, George Smoliga, Vivian O'donnell, Barbara Brito, Carolina Stenfeldt, Luis Rodriguez, Jonathan Arzt (2015) Persistent Foot-and-Mouth Disease Virus Infection in the Nasopharynx of Cattle; Tissue-Specific Distribution and Local Cytokine Expression. 10(5), e0125698.
Stefano Perni, Veera Hakala, Polina Prokopovich (2014) Biogenic synthesis of antimicrobial silver nanoparticles capped with l-cysteine. 460, 219-224.
Rebecca Rafael, F Paula, M Ana, Paula, David Pozo (2010) Silver Nanoparticles Interactions with the Immune System: Implications for Health and Disease.
Murat Şevik, Fahri Ferudun Öztürk (2002) Evaluation of antibody response induced by an oil-adjuvanted inactivated bivalent foot and mouth disease virus vaccine in cattle. 96(1), 11-20.
Sharma (1984) Unknown Title.
S Sharma (1981) Foot and mouth disease in sheep and goats. 4(1), 1-21.
A Singh, D Jain, M Upadhyay, N Khandelwal, H Verma (2010) Green synthesis of silver nanoparticles using Argimonemexicana leaf extract and evaluation of their antimicrobial activities. 5(2), 483-489.
Josiah Smith, Logan Morton, Bret Ulery (2015) Nanoparticles as synthetic vaccines. 34, 217-224.
Sonia Rizk, Abo Agoor, Ekbal Farok, Hind Daoud, Hiam Fakhry (2010) Enhancing effects of Calcium phosphate nanoparticles adjuvant on the Immune response in calves vaccinated with Foot and Mouth Disease trivalent vaccine. 28(2), 1-11.
S Sulic, L Panic, L Dikic (2005) Drtermination of cell growth and malignant transformation. 46(4), 622-638.
B Udapudi, Praveen Kumar Naik, Sabiha Tabassum Savadatti, Rupali Sharma, Samprita Balgi (2012) GLYCYRRHIZA GLABRA MEDIATED SILVER NANOPARTICLES: SYNTHESIS, CHARACTERIZATION, STANDARDIZATION, AND CARDIOPROTECTIVE BIO EVALUATION. 14(5), 10-14.
A Vahid, S Alireza, B Fahimeh, S Sadat, S Mohammad, S Alirezaj, B Razieh, B Rouzbeh, Reza (2016) Green synthesis and evaluation of silver nanoparticles as adjuvant in rabies veterinary vaccine. 11, 3597-3605.
C Venier, M Guthmann, L Fernández, L Fainboim (2007) Innate-immunity cytokines induced by very small size proteoliposomes, a Neisseria-derived immunological adjuvant. 147(2), 379-388.
A Voller, Ann Bartlett, D Bidwell, M Clark, A Adams (1976) The Detection of Viruses by Enzyme-Linked Immunosorbent Assay (ELISA). 33(1), 165-167.
Wael Mossad, Gamal El-Din, Ehab El-Sayed Ibrahim, Hind Daoud, Mohamed Samir, Ali (2014) Humeral and cellular immune response of Egyptian trivalent foot and mouth disease oil vaccine in sheep. 4(4), 178-185.
Kenneth Wong, Stephanie Cheung, Liuming Huang, Jun Niu, Chang Tao, Chi‐ming Ho, Chi‐ming Che, Paul Tam (2009) Further Evidence of the Anti‐inflammatory Effects of Silver Nanoparticles. 4(7), 1129-1135.
Hung‐jen Yen, Shan‐hui Hsu, Ching‐lin Tsai (2009) Cytotoxicity and Immunological Response of Gold and Silver Nanoparticles of Different Sizes. 5(13), 1553-1561.
Y Xu, H Tang, J Liu, H Wang, Y Liu (2013) Evaluation of the adjuvant effect of silver nanoparticles both in vitro and in vivo. 10(1), 42-48.
Zhidong Zhang, Claudia Doel, John Bashiruddin (2015) Interleukin-10 production at the early stage of infection with foot-and-mouth disease virus related to the likelihood of persistent infection in cattle. 46(1), 132.
Liang Zhao, Arjun Seth, Nani Wibowo, Chun-Xia Zhao, Neena Mitter, Chengzhong Yu, Anton Middelberg (2014) Nanoparticle vaccines. 32(3), 327-337.
Published
2020-12-21
Issue
Section
License
Copyright (c) 2020 Authors and Global Journals Private Limited
This work is licensed under a Creative Commons Attribution 4.0 International License.